Emcure Pharmaceuticals Limited (BOM:544210)
India · Delayed Price · Currency is INR 1,961.80
+46.60 (2.43%)
At close: Sep 10, 2026
Emcure Pharmaceuticals Market Cap
Emcure Pharmaceuticals has a market cap or net worth of 375.36 billion as of September 11, 2026. Its market cap has increased by 42.98% in one year.
Market Cap
375.36B
Enterprise Value
389.36B
Revenue
96.83B
Ranking
n/a
PE Ratio
37.11
Stock Price
1,961.80
ChartMarket Cap Chart
Since July 10, 2024, Emcure Pharmaceuticals's market cap has increased from 256.95B to 375.36B, an increase of 46.08%. That is a compound annual growth rate of 19.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 372.30B | 43.93% |
| Dec 31, 2025 | 258.67B | -5.64% |
| Dec 31, 2024 | 274.13B | 6.68% |
| Jul 10, 2024 | 256.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dr. Reddy's Laboratories | 952.27B |
| Abbott India | 535.98B |
| GlaxoSmithKline Pharmaceuticals | 488.93B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Granules India | 218.85B |
| Caplin Point Laboratories | 207.26B |
| AstraZeneca Pharma India | 172.48B |
| Jubilant Pharmova | 161.40B |